Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample by Ying Zhang, Elisa T. Lee, Richard B. Devereux, Jeunliang Yeh, Lyle G. Best, Richard R. Fabsitz, and Barbara V. Howard Hypertension Volume 47(3):410-414 March 1, 2006 Copyright © American Heart Association, Inc. All rights reserved.
Figure 1. Prehypertension prevalence by age group in the Strong Heart Study cohort. Ying Zhang et al. Hypertension. 2006;47:410-414 Copyright © American Heart Association, Inc. All rights reserved.
Figure 2. Cumulative cardiovascular disease incidence during 12 years of follow-up by prehypertension and diabetes status in the Strong Heart Study cohort. Figure 2. Cumulative cardiovascular disease incidence during 12 years of follow-up by prehypertension and diabetes status in the Strong Heart Study cohort. Ying Zhang et al. Hypertension. 2006;47:410-414 Copyright © American Heart Association, Inc. All rights reserved.
Figure 3. Hazard ratios for incident cardiovascular disease associated with prehypertension and glucose metabolic abnormalities on a logarithmic scale. Figure 3. Hazard ratios for incident cardiovascular disease associated with prehypertension and glucose metabolic abnormalities on a logarithmic scale. Hazard ratios compared with the group with normal glucose tolerance and normal blood pressure were adjusted for age, gender, body mass index, waist circumference, low-density and high-density lipoprotein cholesterol, triglycerides, physical activity, smoking and alcohol use. Ying Zhang et al. Hypertension. 2006;47:410-414 Copyright © American Heart Association, Inc. All rights reserved.